Table 3

Parameters requested from individual studies

Creatininemg/dL or µmol/L
Creatinine clearance*mL/min
Diabetes mellitusy/n
Liver diseasey/n
Euroscore 2
UFH or LMWH or fondaparinux (within 24 hours preop)y/n
Procedural variablesUrgency*Elective/urgent/emergency/salvage
CABG indicationStable CAD/NSTEMI/STEMI
CPB timeminutes
No of arterial grafts
No of distal anastomoses
Tranexamic acid during surgeryy/n
Hb preoperativeg/L
Platelets preoperativex109/L
Institutional protocol for treating postpump bleedingy/n
ASS perioperative continuationy/n
ASS cessation prior to surgerydays
Clopidogrel preoperativey/n
Clopidogrel cessation prior to surgerydays
Prasugrel preoperativey/n
Prasugrel cessation prior to surgerydays
Ticagrelor preoperativey/n
Ticagrelor cessation prior to surgerydays
OutcomeChest tube drainage volume within 24 hours†ml
Reoperation due to bleedingy/n
Intracranial bleeding within 48 hours perioperativelyy/n
No of transfused red blood cell units within 48 hours from incision
Postoperative MIy/n
In-hospital mortalityy/n
30-day mortalityy/n
  • *Part of euroscore II.

  • †If unavailable chest tube drainage volume obtained during shorter observation period (define observation period).

  • ASS, Aspirin; BMI, body mass index; CABG, coronary artery bypass grafting; CAD, Coronary Artery Disease; CPB, Cardiopulmonary Bypass; Hb, Haemoglobin; LMWH, Low Molecular Weight Heparin; LVEF, Left ventricular ejection fraction ; MI, Myocardial infarction; NSTEMI, Non-ST-Elevation Myocardial Infarction; STEMI, ST-Elevation Myocardial Infarction; UFH, Unfractionated heparin.